LEASON ELLIS SHOWS MEDICAL DIAGNOSTIC PATENTS CAN STILL BE OBTAINED IN THE U.S.
The USPTO Patent Trials and Appeal Board in Ex parte Michael Donovan et al. recently reversed the patent examiner’s rejection of claims in the medical diagnostic/prognostic arts on the ground of ineligible subject matter. This decision, issued two months after the USPTO issued its January 2019 Revised Patent Subject Matter Eligibility Guidance, and the implications for applicants seeking U.S. patents for medical diagnostic/prognostic technologies is discussed in this article.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.